1. Home
  2. VCYT vs IDT Comparison

VCYT vs IDT Comparison

Compare VCYT & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • IDT
  • Stock Information
  • Founded
  • VCYT 2006
  • IDT 1990
  • Country
  • VCYT United States
  • IDT United States
  • Employees
  • VCYT N/A
  • IDT N/A
  • Industry
  • VCYT Medical Specialities
  • IDT Telecommunications Equipment
  • Sector
  • VCYT Health Care
  • IDT Telecommunications
  • Exchange
  • VCYT Nasdaq
  • IDT Nasdaq
  • Market Cap
  • VCYT 2.1B
  • IDT 1.4B
  • IPO Year
  • VCYT 2013
  • IDT 1996
  • Fundamental
  • Price
  • VCYT $23.59
  • IDT $57.41
  • Analyst Decision
  • VCYT Buy
  • IDT
  • Analyst Count
  • VCYT 9
  • IDT 0
  • Target Price
  • VCYT $39.89
  • IDT N/A
  • AVG Volume (30 Days)
  • VCYT 996.0K
  • IDT 210.1K
  • Earning Date
  • VCYT 08-06-2025
  • IDT 06-05-2025
  • Dividend Yield
  • VCYT N/A
  • IDT 0.42%
  • EPS Growth
  • VCYT N/A
  • IDT 170.83
  • EPS
  • VCYT 0.41
  • IDT 3.79
  • Revenue
  • VCYT $463,393,000.00
  • IDT $1,223,733,000.00
  • Revenue This Year
  • VCYT $12.55
  • IDT $2.59
  • Revenue Next Year
  • VCYT $9.79
  • IDT $0.40
  • P/E Ratio
  • VCYT $57.33
  • IDT $15.15
  • Revenue Growth
  • VCYT 23.42
  • IDT 1.91
  • 52 Week Low
  • VCYT $19.73
  • IDT $33.84
  • 52 Week High
  • VCYT $47.32
  • IDT $71.12
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 34.13
  • IDT 35.70
  • Support Level
  • VCYT $22.61
  • IDT $56.12
  • Resistance Level
  • VCYT $27.91
  • IDT $57.81
  • Average True Range (ATR)
  • VCYT 1.05
  • IDT 2.02
  • MACD
  • VCYT -0.25
  • IDT -0.81
  • Stochastic Oscillator
  • VCYT 18.51
  • IDT 10.92

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

Share on Social Networks: